DEPDC1B and rhabdomyosarcoma: DEPDC1B overexpression also increases phosphorylation of ERK,3, 5 and the MEK/ERK pathway controls myoblast proliferation, while MEK inhibition in RAS‐mutated rhabdomyosarcoma can induce myogenic differentiation.